Covered recipient · General Payments record
NEETA R MOTIWALA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,320.85
- Reported across 118 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $721.90 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $194.18 | 5 |
| Corcept Therapeutics | $165.25 | 3 |
| CVRx Inc. | $149.35 | 1 |
| IBSA Pharma Inc. | $125.00 | 1 |
| GlaxoSmithKline, LLC. | $31.39 | 2 |
| Astellas Pharma US Inc | $21.93 | 1 |
| Cleerly, Inc. | $19.50 | 1 |
| Echosens North America, Inc. | $15.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $21.93 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139411017 | CMS |
| Cleerly, Inc. | $19.50 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144711964 | CMS |
| Corcept Therapeutics | $28.57 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117751718 | CMS |
| Corcept Therapeutics | $118.20 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117751772 | CMS |
| Corcept Therapeutics | $18.48 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117751732 | CMS |
| CVRx, Inc. | $149.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133237427 | CMS |
| Echosens North America, Inc. | $15.30 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154982720 | CMS |
| GlaxoSmithKline, LLC. | $16.39 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116721689 | CMS |
| GlaxoSmithKline, LLC. | $15.00 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116319792 | CMS |
| IBSA Pharma Inc. | $125.00 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142976970 | CMS |
| Novo Nordisk Inc | $18.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096566300 | CMS |
| Novo Nordisk Inc | $14.91 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097028014 | CMS |
| Novo Nordisk Inc | $16.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096637395 | CMS |
| Novo Nordisk Inc | $18.70 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096648301 | CMS |
| Novo Nordisk Inc | $124.98 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615968 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.